11.09.2023 - New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease.Results corroborate prior research from other academic researchers.These data once again confirm the biological activity of simufilam. . Seite 1
(SAVA), Biogen Idec Inc (NASDAQ:BIIB) - Cassava Sciences Stock Soars In Anticipation Of Alzheimer s Data: A Technical Analysis benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.